AVOCENT CORP 4

4 · AVOCENT CORP · Filed Feb 11, 2005

Form 4

Period: 2005-02-09

Senior VP, Engineering

Transactions

Exercise/Conversion
Options (rights to buy)
2005-02-09−40,000→ 0 total
Exercise: $22.36From: 2001-05-25Exp: 2011-05-25→ Common Stock (40,000 underlying)
Exercise/Conversion
Options (rights to buy)
2005-02-09−15,000→ 0 total
Exercise: $26.94From: 2000-05-02Exp: 2010-05-02→ Common Stock (15,000 underlying)
Exercise/Conversion
Common Stock
2005-02-09$22.36/sh+40,000$894,400→ 56,000 total
Sale
Common Stock
2005-02-09$35.60/sh−55,000$1,958,000→ 1,000 total
Exercise/Conversion
Common Stock
2005-02-09$26.94/sh+15,000$404,100→ 16,000 total

Holdings

Options (rights to buy)
Exercise: $21.77From: 2002-04-15Exp: 2012-04-15→ Common Stock (40,000 underlying)
40,000
Options (rights to buy)
Exercise: $52.44From: 2000-09-18Exp: 2010-09-18→ Common Stock (175,000 underlying)
175,000
Option (rights to buy)
Exercise: $40.98From: 2004-02-05Exp: 2014-02-05→ Common Stock (30,000 underlying)
30,000
Options (rights to buy)
Exercise: $28.96From: 2004-08-19Exp: 2014-08-19→ Common Stock (10,000 underlying)
10,000

Footnotes (3)

[F1]Grant date, 50% vest and become exercisable on the first anniversary of the grant date and 25% on each grant date anniversary for the following two years.
[F2]Grant date, 15% vests every 6 months for the first 12 months, 6.25% vests every three months for the following twelve months and 5% vests every three months for the final 12 months.
[F3]Grant date, 25% vests after 6 months, 7.5% vests every three months for final 10 quarters.

Documents

1 file